World's Best Scientists 2026 revealed!

Joseph Makhema publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Joseph Makhema sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

The last bar groups every scientist with 807 publications or more.

Joseph Makhema D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph Makhema sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

The last bar groups every scientist with 157 D-Index or more.

Overview

Joseph Makhema is affiliated with Harvard University in the United States and works primarily in the field of Medicine, with a significant focus on Infectious Diseases. Their research spans multiple subfields including Epidemiology, Virology, Pediatrics, Perinatology and Child Health, as well as Obstetrics and Gynecology. This interdisciplinary approach supports their extensive work on HIV/AIDS and related health issues.

The scientist's main topics of research revolve around HIV/AIDS Research and Interventions, HIV Research and Treatment, and HIV/AIDS drug development and treatment. They also contribute to studies on Hepatitis B and C viruses, and issues in Global Maternal and Child Health, demonstrating a broad engagement with infectious diseases and public health concerns.

Joseph Makhema has contributed to numerous publications across various reputable venues. Frequent publication outlets include PLoS ONE, AIDS, Viruses, the Journal of the International AIDS Society, and UNC Libraries, where they have multiple works published.

Among the notable papers associated with their work are:

  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition, 2021, New England Journal of Medicine
  • Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial, 2022, The Lancet
  • Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition, 2022, Nature Medicine
  • Weight gain during pregnancy among women initiating dolutegravir in Botswana, 2020, EClinicalMedicine
  • Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in Botswana, 2022, The Lancet Global Health

Their research collaborations feature several frequently co-authoring scientists, including Shahin Lockman, Roger Shapiro, Sikhulile Moyo, Mompati Mmalane, and Simani Gaseitsiwe. These collaborations indicate a strong network in research focused on HIV and related infectious diseases.

Best Publications

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana.

    Sheri Weiser;William Wolfe;William Wolfe;David Bangsberg;Ibou Thior

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

    Beatriz Grinsztejn;Mina C. Hosseinipour;Heather J. Ribaudo;Susan Swindells

  • Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

    C. Celum;A. Wald;A. Wald;J.R. Lingappa;A.S. Magaret;A.S. Magaret

  • Antiretroviral Regimens in Pregnancy and Breast-Feeding in Botswana

    R. L. Shapiro;A. Ogwu;D. Kitch;S. Lockman

  • Maternal or infant antiretroviral drugs to reduce HIV-1 transmission

    Charles S. Chasela;Michael G. Hudgens;Denise J. Jamieson;Dumbani Kayira

  • Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine

    Shahin Lockman;Roger L Shapiro;Laura M Smeaton;Carolyn Wester

  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    Lawrence Corey;Peter B Gilbert;Michal Juraska;David C Montefiori

  • Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana

    Rebecca Zash;Lewis Holmes;Modiegi Diseko;Denise L. Jacobson

  • Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

    Jennifer Y. Chen;Heather J. Ribaudo;Sajini Souda;Natasha Parekh

  • Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey

    Tendani Gaolathe;Kathleen E Wirth;Molly Pretorius Holme;Joseph Makhema

  • Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana

    Joseph Makhema;Kathleen E Wirth;Molly Pretorius Holme;Tendani Gaolathe

  • Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial.

    Jairam R. Lingappa;Barrot Lambdin;Elizabeth Ann Bukusi;Kenneth Ngure

  • Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

    Jairam R Lingappa;Jared M Baeten;Anna Wald;James P Hughes

  • Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

    Rebecca Zash;Denise L. Jacobson;Modiegi Diseko;Gloria Mayondi

  • Infant Morbidity, Mortality, and Breast Milk Immunologic Profiles among Breast-Feeding HIV-Infected and HIV-Uninfected Women in Botswana

    Roger L Shapiro;Shahin Lockman;Soyeon Kim;Laura Smeaton

  • Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana

    William R. Wolfe;S. D. Weiser;D. R. Bangsberg;I. Thior

  • Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: implications for active and passive immunization

    Cecilia Rademeyer;Bette Korber;Michael S Seaman;Elena E Giorgi

  • Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study

    Rebecca Zash;Denise L Jacobson;Modiegi Diseko;Gloria Mayondi

Frequent Co-Authors

Richard Marlink
Richard Marlink Rutgers, The State University of New Jersey
Myron Essex
Myron Essex Harvard University
Myron S. Cohen
Myron S. Cohen University of North Carolina at Chapel Hill
Susan H. Eshleman
Susan H. Eshleman Johns Hopkins University School of Medicine
Beatriz Grinsztejn
Beatriz Grinsztejn Oswaldo Cruz Foundation
Amalia Magaret
Amalia Magaret University of Washington
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Anna Wald
Anna Wald University of Washington
M. Juliana McElrath
M. Juliana McElrath University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open doors to various healthcare and research career pathways. For professionals interested in nursing, exploring programs like top psychiatric mental health nurse practitioner programs online can provide specialized clinical training alongside immunological studies. These programs often combine mental health expertise with pathology knowledge, broadening career opportunities.

Cost is an important consideration for many students. Accessing cheapest pmhnp programs helps prospective students find budget-friendly options without sacrificing quality. This makes advanced education more attainable for those aiming to work in immunology-related nursing fields.

Those progressing into advanced practice roles should be aware of earning potential. Understanding the doctor of nursing practice salary across states can guide decisions about where to practice and specialize. Competitive salaries often reflect high-demand immunological and healthcare skills.

For nurse practitioners looking to expand their expertise, transitioning to roles such as acute care may require additional certification. Resources like acute care certification for fnp offer guidance on how to navigate professional advancement, which can complement an immunology-focused career.

Best Scientists Citing Joseph Makhema

Trending Scientists

Recently Published Articles